Hospitalization costs in schizophrenia (SC) and projection of costs with the adoption of a long-term release formulation of paliperidone palmitate (LRPP)- real world data analysis
May 1, 2014, 00:00 AM
10.1016/j.jval.2014.03.1257
https://www.valueinhealthjournal.com/article/S1098-3015(14)01308-4/fulltext
Section Title :
Mental Health
Section Order :
725
First Page :
A215
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)01308-4&doi=10.1016/j.jval.2014.03.1257